Transcode Therapeutics, Inc.

RNAZ·NASDAQ·$5.39Share Price as of 11/2·$5MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-K/AFY 202504/30/26 10-KFY 202504/15/26 10-QQ3 ended 09/30/2511/14/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report10/01/26 8-KCurrent report09/28/26 8-KCurrent report09/11/26 8-KCurrent report08/03/26

Prospectuses and Registrations

424B3Prospectus07/20/26 424B3Prospectus07/20/26 S-1Registration statement (IPO)05/01/26 S-3Shelf registration04/30/26 S-3Shelf registration12/12/25

Proxies

DEFA14AAdditional proxy materials07/17/26 DEF 14ADefinitive proxy06/02/26 DEFA14AAdditional proxy materials05/26/26 PRE 14APreliminary proxy05/08/26 DEFA14AAdditional proxy materials04/07/26

Ownership

Form 3Initial insider ownership09/21/26 Form 4Insider transaction09/11/26 Form 3Initial insider ownership08/05/26 Form 4Insider transaction08/05/26 SC 13D/ABeneficial ownership (amended)08/03/26

Other

ARSAnnual report to shareholders06/02/26 EFFECTRequest for effectiveness05/19/26 EFFECTRequest for effectiveness05/19/26 CORRESPCorrespondence with the SEC05/15/26 CORRESPCorrespondence with the SEC05/15/26